Article3 Biotech2025

Neuroprotective propensity of N-(5-chloro-2-hydroxyphenyl)-2-(morpholin-4-yl-methyl) benzamide, an inventive calcineurin inhibitor, in biological models of Parkinson's disease.

R M Nivya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.